Literature DB >> 28496884

Left Atrial Thrombus Despite Anticoagulation: The Importance Of Homocysteine.

J David Spence1.   

Abstract

Patients in atrial fibrillation may have left atrial thrombi or strokes despite adequate anticoagulation. It is important to consider elevated plasma total homocysteine (tHcy) as a treatable clotting factor that may explain such cases. Metabolic B12 deficiency is common even in patients with a "normal" serum B12. Measurement of holotranscobalamin, methylmalonic acid or, in folate-replete patients, tHcy are necessary to diagnose metabolic B12 deficiency when the serum B12 is below 400 pmol/L. Elevated tHcy quadruples the risk of stroke in atrial fibrillation, and is far more common than the usual clotting factors for which testing is commonly performed: among patients attending.

Entities:  

Year:  2013        PMID: 28496884      PMCID: PMC5153242          DOI: 10.4022/jafib.930

Source DB:  PubMed          Journal:  J Atr Fibrillation        ISSN: 1941-6911


  14 in total

1.  Understanding the complexity of homocysteine lowering with vitamins: the potential role of subgroup analyses.

Authors:  J David Spence; Meir J Stampfer
Journal:  JAMA       Date:  2011-12-21       Impact factor: 56.272

2.  Tutorial in biostatistics: Analyzing associations between total plasma homocysteine and B vitamins using optimal categorization and segmented regression.

Authors:  Heejung Bang; Madhu Mazumdar; David Spence
Journal:  Neuroepidemiology       Date:  2006-10-11       Impact factor: 3.282

3.  Mechanisms of thrombogenesis in atrial fibrillation.

Authors:  David Spence
Journal:  Lancet       Date:  2009-03-21       Impact factor: 79.321

Review 4.  Nutrition and stroke prevention.

Authors:  J David Spence
Journal:  Stroke       Date:  2006-07-27       Impact factor: 7.914

5.  The usefulness of holotranscobalamin in predicting vitamin B12 status in different clinical settings.

Authors:  Wolfgang Herrmann; Rima Obeid; Heike Schorr; Jürgen Geisel
Journal:  Curr Drug Metab       Date:  2005-02       Impact factor: 3.731

6.  Culprit factors for the failure of well-conducted warfarin therapy to prevent ischemic events in patients with atrial fibrillation: the role of homocysteine.

Authors:  Daniela Poli; Emilia Antonucci; Emanuele Cecchi; Rossella Marcucci; Agatina Alessandrello Liotta; Anna Paola Cellai; Meri Lenti; Gian Franco Gensini; Rosanna Abbate; Domenico Prisco
Journal:  Stroke       Date:  2005-09-22       Impact factor: 7.914

7.  Determinants of plasma methylmalonic acid in a large population: implications for assessment of vitamin B12 status.

Authors:  Anna Vogiatzoglou; Abderrahim Oulhaj; A David Smith; Eha Nurk; Christian A Drevon; Per M Ueland; Stein E Vollset; Grethe S Tell; Helga Refsum
Journal:  Clin Chem       Date:  2009-10-15       Impact factor: 8.327

8.  Homocysteine lowering with folic acid and B vitamins in vascular disease.

Authors:  Eva Lonn; Salim Yusuf; Malcolm J Arnold; Patrick Sheridan; Janice Pogue; Mary Micks; Matthew J McQueen; Jeffrey Probstfield; George Fodor; Claes Held; Jacques Genest
Journal:  N Engl J Med       Date:  2006-03-12       Impact factor: 91.245

9.  Holotranscobalamin in laboratory diagnosis of cobalamin deficiency compared to total cobalamin and methylmalonic acid.

Authors:  Rima Obeid; Wolfgang Herrmann
Journal:  Clin Chem Lab Med       Date:  2007       Impact factor: 3.694

10.  Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial.

Authors:  Pilar Galan; Emmanuelle Kesse-Guyot; Sébastien Czernichow; Serge Briancon; Jacques Blacher; Serge Hercberg
Journal:  BMJ       Date:  2010-11-29
View more
  1 in total

1.  Plasma Total Homocysteine Level Is Related to Unfavorable Outcomes in Ischemic Stroke With Atrial Fibrillation.

Authors:  Ki-Woong Nam; Chi Kyung Kim; Sungwook Yu; Kyungmi Oh; Jong-Won Chung; Oh Young Bang; Gyeong-Moon Kim; Jin-Man Jung; Tae-Jin Song; Yong-Jae Kim; Bum Joon Kim; Sung Hyuk Heo; Kwang-Yeol Park; Jeong-Min Kim; Jong-Ho Park; Jay Chol Choi; Man-Seok Park; Joon-Tae Kim; Kang-Ho Choi; Yang Ha Hwang; Woo-Keun Seo
Journal:  J Am Heart Assoc       Date:  2022-04-26       Impact factor: 6.106

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.